Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Telmisartan Dispersible Tablets

Approval Number

国药准字H20140032

Company浙江泰利森药业有限公司

Registration Date

February 7, 2024

Drug Information

Generic Name

替米沙坦分散片

Brand Name

纳泽

Dosage Form

片剂

Strength

40mg

Drug Type

化学药品

Registration Date

February 7, 2024

Company Information

Applicant Company

Company Name浙江泰利森药业有限公司

Company Address

浙江省海盐经济开发区新桥北路200号

Manufacturing Company

Company Name浙江泰利森药业有限公司

Company Address

浙江省海盐经济开发区新桥北路200号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

替米沙坦分散片 - NMPA 批准文号 | MedPath